Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Sigma Healthcare Ltd

Healthcare AU SIG

2.72AUD
-0.03(1.09%)

Last update at 2026-03-11T05:21:00Z

Day Range

2.692.75
LowHigh

52 Week Range

2.673.24
LowHigh

Fundamentals

  • Previous Close 2.75
  • Market Cap32322.37M
  • Volume11602051
  • P/E Ratio56.00
  • Dividend Yield0.47%
  • EBITDA933.20M
  • Revenue TTM9546.70M
  • Revenue Per Share TTM0.85
  • Gross Profit TTM 1770.78M
  • Diluted EPS TTM0.05

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Income before tax 11.15M 8.62M 5.46M -8.30700M 51.75M
Minority interest -0.92400M -0.80200M -1.21600M -0.90300M 0.69M
Net income -13.84200M 4.51M 3.03M -6.33600M 59.76M
Selling general administrative 117.69M 88.62M 82.62M 93.02M 68.79M
Selling and marketing expenses 333.66M 173.15M 210.38M 216.58M 214.61M
Gross profit 334.05M 189.82M 320.63M 296.51M 289.06M
Reconciled depreciation 25.81M 28.32M 30.34M 27.69M 30.99M
Ebit 29.66M 24.93M 26.86M 4.18M 34.20M
Ebitda 55.47M 53.25M 57.19M 31.87M 65.19M
Depreciation and amortization 25.81M 28.32M 30.34M 27.69M 30.99M
Non operating income net other - - - - -
Operating income -10.08100M -71.94800M 26.86M 4.18M 34.20M
Other operating expenses 4904.02M 3394.01M 3735.65M 3556.35M 3475.58M
Interest expense 18.51M 16.30M 14.41M 10.84M 11.82M
Tax provision 24.06M 3.31M 2.44M -1.97100M -9.50400M
Interest income 8.00M 1.72M 0.60M 0.22M 11.46M
Net interest income -10.51100M -14.57900M -13.81000M -10.62000M -11.46300M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 24.06M 3.31M 2.44M -1.97100M -9.50400M
Total revenue 4893.94M 3322.06M 3726.46M 3515.56M 3450.24M
Total operating expenses 344.13M 261.77M 329.82M 337.29M 314.39M
Cost of revenue 4559.88M 3132.24M 3405.83M 3219.06M 3161.19M
Total other income expense net 21.23M -83.13100M -21.39600M -12.48800M 17.54M
Discontinued operations - - - - -
Net income from continuing ops -12.91800M 5.31M 3.03M -6.33600M 61.25M
Net income applicable to common shares -13.84200M 4.51M 1.81M -7.23900M 59.76M
Preferred stock and other adjustments - - - - -
Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Total assets 1830.57M 1404.13M 1174.07M 1248.28M 1205.62M
Intangible assets 19.65M 20.00M 22.90M 25.09M 55.10M
Earning assets - - - - -
Other current assets 26.06M 14.91M 11.87M 50.17M 9.63M
Total liab 991.29M 531.52M 696.31M 759.50M 670.71M
Total stockholder equity 837.86M 870.77M 475.92M 487.19M 534.22M
Deferred long term liab - - - - -
Other current liab 126.77M 57.99M 57.45M 77.76M 82.32M
Common stock 1641.07M 1682.37M 1234.46M 1225.45M 1219.91M
Capital stock 1641.07M 1637.02M 1234.46M 1225.45M 1219.91M
Retained earnings -799.52900M -769.17600M -761.58700M -741.13400M -690.92300M
Other liab - - 4.91M 4.15M 7.24M
Good will 89.06M 89.06M 95.22M 102.96M 102.96M
Other assets - - 61.68M 59.40M 41.77M
Cash 14.57M 356.50M 16.65M 31.14M 16.13M
Cash and equivalents - - - - -
Total current liabilities 864.97M 371.28M 477.36M 457.61M 523.66M
Current deferred revenue 1.17M 0.14M 0.96M 1.89M 0.46M
Net debt 117.51M -219.86500M 210.34M 292.29M 199.10M
Short term debt 10.64M 9.79M 12.94M 25.69M 75.41M
Short long term debt - - 3.68M 15.38M 66.38M
Short long term debt total 132.09M 136.63M 226.99M 323.43M 215.23M
Other stockholder equity - -45.34900M 0.22M 2.87M 5.23M
Property plant equipment - - 290.92M 281.56M 288.29M
Total current assets 1376.79M 912.50M 685.85M 761.63M 702.20M
Long term investments 8.52M 13.62M 16.08M 17.63M 15.30M
Net tangible assets - - 357.68M 359.14M 376.16M
Short term investments - - 0.00000M 0.01M 0.00000M
Net receivables 952.72M 319.96M 332.48M 358.68M 327.30M
Long term debt - - 80.00M 165.00M 0.00000M
Inventory 383.44M 221.13M 324.85M 321.64M 349.14M
Accounts payable 726.38M 303.36M 406.01M 352.27M 365.47M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -3.68000M 2.92M 3.04M 2.87M 5.23M
Additional paid in capital - - - - -
Common stock total equity - - - - 1219.91M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 38.73M 1.19M 1.31M 0.78M 1.43M
Deferred long term asset charges - - - - -
Non current assets total 453.78M 491.63M 488.23M 486.65M 503.42M
Capital lease obligations 132.09M 136.63M 143.30M 143.06M 148.85M
Long term debt total - - 214.04M 297.74M 139.82M
Breakdown 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Type yearly yearly yearly yearly yearly
Date 2025-01-31 2024-01-31 2023-01-31 2022-01-31 2021-01-31
Investments -1.59900M 5.73M -28.60400M -2.38700M -6.33200M
Change to liabilities - - 53.54M -7.11200M 5.14M
Total cashflows from investing activities -1.59900M 5.73M -28.60400M -16.59200M 98.76M
Net borrowings 323.89M -80.00000M -101.88000M 148.62M -264.56400M
Total cash from financing activities -24.73000M 295.82M -116.94100M 128.89M -265.71100M
Change to operating activities - - 16.64M -51.52300M 6.69M
Net income -13.84200M 4.51M 3.03M -7.23900M 59.76M
Change in cash -341.92200M 343.53M -2.80100M 66.02M -154.48300M
Begin period cash flow 356.50M 12.97M 15.77M -50.25100M 104.23M
End period cash flow 14.57M 356.50M 12.97M 15.77M -50.25100M
Total cash from operating activities -315.59100M 41.97M 33.36M 27.69M 12.47M
Issuance of capital stock 2.68M 396.12M 0.88M 0.20M 0.49M
Depreciation - 28.32M 30.34M 27.69M 30.99M
Other cashflows from investing activities -151.60900M 8.93M 0.80M -0.00100M 175.80M
Dividends paid -17.13200M -9.98100M 15.94M 19.93M 1.59M
Change to inventory -57.25500M 103.72M -3.21100M 27.50M -33.64500M
Change to account receivables -103.75200M 10.88M 27.50M -30.73200M -30.92500M
Sale purchase of stock 2.68M -9.50200M 0.88M 0.20M -0.05000M
Other cashflows from financing activities -334.16700M -10.31100M -16.88000M 148.62M -14.56400M
Change to netincome - - 23.43M 9.39M -20.82400M
Capital expenditures 7.91M 4.72M 29.40M 14.20M 77.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -336.17200M 16.29M 0.60M 0.22M 0.36M
Stock based compensation - 2.75M - - -
Other non cash items 20.58M -2.64700M -33.36300M -20.45200M -90.74900M
Free cash flow -323.50100M 37.25M 3.96M 13.49M -64.56100M

Peer Comparison

Sector: Healthcare Industry: Medical Distribution

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
SIG
Sigma Healthcare Ltd		 -0.03 1.09% 2.72 56.00 38.17 3.39 6.43 5.56 40.06
EBO
Ebos Group Ltd		 -0.32 1.68% 18.72 18.43 17.01 0.31 1.51 0.47 10.81
PGC
Paragon Care Ltd		 -0.005 2.70% 0.18 - 5.98 0.09 0.98 0.18 17.79
MYX
Mayne Pharma Group Ltd		 0.18 7.29% 2.65 - 263.16 0.49 0.55 0.42 5.70
CYC
Cyclopharm Ltd		 0.04 5.48% 0.77 - 116.28 2.78 3.29 5.41 -24.5712

Reports Covered

Stock Research & News

View All

Profile

Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores brand names. It also offers products through online. The company was founded in 1912 and is headquartered in Clayton, Australia.

Sigma Healthcare Ltd

2125 Dandenong Road, Clayton, VIC, Australia, 3168

Key Executives

Name Title Year Born
Mr. Vikesh Ramsunder B.Com. CEO, MD & Director 1971
Mr. Nigel Simonsz Chief Financial Officer NA
Mr. Martin Hawkins Chief Information Officer NA
Ms. Kara McGowan Company Sec. & Gen. Counsel NA
Mr. Mark Conway B.Com., M.B.A. Chief Financial Officer NA
Ms. Kara McGowan A.C.I.S., L.L.B. Company Secretary & General Counsel NA
Mr. Gary Woodford Head of Corporate Affairs NA
Mr. Mark Conway B.Com., M.B.A. Chief Financial Officer NA
Ms. Kara McGowan A.C.I.S., L.L.B. Company Secretary & General Counsel NA
Mr. Gary Woodford Head of Corporate Affairs NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.